23rd September 2022
- 0 comments
Swiss techbio company Hedera Dx, founded in 2021 by veteran healthcare entrepreneurs and executives, has raised €14m to support the launch this Autumn of a blood-based testing solution to profile cancer DNA circulating in the blood, helping patients access better treatments.
...Register / Login now to read full story
In order to read the full story we need you to be registered with us, please click the links below to login or register.
Back to Homepage